0% found this document useful (0 votes)
52 views6 pages

Overview of Streptococcus Agalactiae

Streptococcus agalactiae (Group B Strep) is a facultative anaerobic, encapsulated bacterium that commonly colonizes the human genital and GI tracts. It is a leading infectious agent in pregnant individuals, neonates, and immunocompromised adults, causing diseases like chorioamnionitis, sepsis, and meningitis. Virulence factors like capsular polysaccharides and adhesins enhance its ability to invade tissues and evade the immune system. Pregnancy, neonates, and chronic illnesses increase risk of infection. Treatment involves antibiotics like penicillin.

Uploaded by

Woo Rin Park
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
52 views6 pages

Overview of Streptococcus Agalactiae

Streptococcus agalactiae (Group B Strep) is a facultative anaerobic, encapsulated bacterium that commonly colonizes the human genital and GI tracts. It is a leading infectious agent in pregnant individuals, neonates, and immunocompromised adults, causing diseases like chorioamnionitis, sepsis, and meningitis. Virulence factors like capsular polysaccharides and adhesins enhance its ability to invade tissues and evade the immune system. Pregnancy, neonates, and chronic illnesses increase risk of infection. Treatment involves antibiotics like penicillin.

Uploaded by

Woo Rin Park
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

NOTES

NOTES
STREPTOCOCCUS

MICROBE OVERVIEW
Morphology ▪ Produce extracellular substances
▪ Spherical, Gram-positive bacteria; appear in (e.g. cytolysins, enzymes) → enhance
chains/pairs; catalase, coagulase negative pathogenicity

STREPTOCOCCUS AGALACTIAE
(GROUP B STREP)
[Link]/streptococcus-agalactiae
▪ Direct cytotoxicity to host phagocytes
PATHOLOGY & CAUSES
Common infectious agent
▪ AKA Group B Streptococcus (GBS) ▪ Adults (nonpregnant)
▪ Encapsulated, facultative anaerobe ▫ Broad spectrum of infections
▪ Colonizes human genital, gastrointestinal ▪ Pregnant individuals
(GI) tracts; upper respiratory tracts of young ▫ Chorioamnionitis
infants
▪ Neonates
▪ Beta-hemolytic
▫ GBS infection, sepsis
▫ Blood agar plates, hemolysins degrade
lipid membranes → colonies surrounded
by narrow zone of hemolyzed cells → RISK FACTORS
complete (beta-)hemolysis ▪ Adults (nonpregnant)
▫ Chronic disease (e.g. diabetes, liver
Virulence factors disease, malignancy; > age 65, esp.
▪ Complex capsular polysaccharides residents of nursing homes)
▫ Inhibit complement deposition on ▪ Pregnancy
microbe surface components ▪ Neonates
▪ Hypervirulent GBS adhesin (HvgA) ▫ Ascending infection from mother (e.g.
▫ ↑ ability to invade blood-brain barrier rupture of membranes, chorioamnionitis)
▪ Cluster of virulence responder/sensor ▪ Hospitalization
(CovR/S) mutation ▫ Nosocomial/hospital-acquired infections
▫ Accelerate failure of amniotic barrier
→ ↑ ability to penetrate chorioamniotic
membranes
▪ Pilins
▫ Act as adhesins → ↑ ability to invade
central nervous system, form biofilm

552 [Link]
Chapter 99 Streptococcus

COMPLICATIONS ▪ Hippurate hydrolysis test


▪ Cystitis, pyelonephritis, urethritis, ▫ Detections hippurate hydrolysis by GBS
prostatitis; osteomyelitis, septic arthritis;
endocarditis; meningitis; pneumonia; sepsis;
toxic shock-like syndrome
OTHER DIAGNOSTICS
▪ Clinical history, physical examination
▪ Neonates
▫ Preterm birth, bacteremia, sepsis,
pneumonia, meningitis, neonatal TREATMENT
mortality
MEDICATIONS
SIGNS & SYMPTOMS ▪ Antibiotics (e.g. penicillin G, ampicillin)

▪ Fever, chills; malaise; cough OTHER INTERVENTIONS


▪ Local tissue infection ▪ Prenatal screening
▫ Red, warm, swollen, presence of
drainage

DIAGNOSIS
LAB RESULTS
Identification of microbe
▪ E.g. blood, cerebrospinal fluid
▪ Gram stain, characteristic morphology
▪ Culture
▫ Beta-hemolysis on blood agar
Figure 99.1 The three classes of
▪ CAMP test streptococcus cultured on a blood agar plate.
▫ Identifies presence of CAMP factor Alpha (left) shows partial hemolysis, beta
▪ Latex agglutination tests (centre) shows complete hemolysis and
▫ Detects antibodies produced in gamma (right) shows no hemolysis.
response to GBS

STREPTOCOCCUS PNEUMONIAE
[Link]/streptococcus-pneumoniae
▪ Virulence factors
PATHOLOGY & CAUSES ▫ Resistance to phagocytosis (conferred
by 92 polysaccharide serotypes)
▪ Causative agent for numerous clinical
▫ Adherence proteins
syndromes in children, older adults
▫ Biofilm formation
▪ Alpha-hemolytic, lancet-shaped diplococci
▫ Pneumolysin toxin
▪ Lysis by bile (deoxycholate), optochin
sensitive ▪ Asymptomatic colonization → direct spread
from site of colonization,hematogenous
▪ Fastidious; prefers 5% carbon dioxide
spread → clinical syndromes
▪ Pyogenic

[Link] 553
▪ Typical infections caused by S. pneumoniae
range from mucosal to invasive diseases DIAGNOSIS
▫ Meningitis
DIAGNOSTIC IMAGING
▫ Otitis media
▫ Pneumococcal community-acquired Chest X-ray
pneumonia ▪ Infiltration, consolidation (pneumonia)
▫ Sinusitis
LAB RESULTS
RISK FACTORS
Identification of organism
▪ Age (< 2, ≥ 65 years)
▪ Gram-positive diplococci, positive culture,
▪ Underlying disease (e.g. liver, kidney, heart,
polymerase chain reaction (PCR)
lung, diabetes, malignancies)
▪ Urine antigen analysis (bacteremia)
▪ Crowded conditions (e.g. daycare centers,
military camps, prisons)
▪ Immunodeficiency (e.g. HIV, genetic OTHER DIAGNOSTICS
immune defects, solid organ/bone ▪ Clinical history, physical examination
transplant)
▪ Smoking, alcohol abuse
TREATMENT
COMPLICATIONS MEDICATIONS
▪ Pneumococcal endocarditis, empyema, ▪ Antibiotics
bacteremia, sepsis
▫ Pneumonia: beta-lactam antibiotic
▫ Otitis media: amoxicillin-clavulanate
SIGNS & SYMPTOMS (children)
▫ Sinusitis: amoxicillin (amoxicillin–
▪ Common clinical presentation clavulanic acid may be preferable)
▫ Fever, altered mental status, malaise
▪ Typical findings related to clinical syndrome OTHER INTERVENTIONS
▫ Meningitis: headache, neck stiffness
Prevention
▫ Otitis media: ↓ tympanic membrane
▪ Pneumococcal vaccine
mobility/bulging membrane, otorrhea,
pain
▫ Pneumonia: cough, bronchial breath
sounds, rales
▫ Sinusitis: purulent rhinitis, mucous
membrane edema, headache

554 [Link]
Chapter 99 Streptococcus

STREPTOCOCCUS PYOGENES
(GROUP A STREP)
[Link]/streptococcus-pyogenes
▪ Pyrogenic exotoxins (type A, B, C)
PATHOLOGY & CAUSES ▫ Induce fever, act as superantigens
→ T-cell proliferation → ↑ cytokine
▪ AKA Group A Streptococcus (GAS) production → promotes shock
▪ Colonizes human skin, mucous membranes ▪ Streptococcal inhibitor of complement (SIC)
▪ Cell-wall structure ▫ Inactivates complement membrane
▫ Peptidoglycan backbone + lipoteichoic attack complex
acid components → structural stability ▪ Opacity factor (OF)
▪ Beta-hemolytic ▫ Lipoprotein lipase
▫ Blood agar plates, hemolysins degrade
lipid membranes → colonies surrounded Causative agent in several disorders
by clear zone of hemolyzed cells → ▪ Pyogenic diseases
complete (beta-) hemolysis ▫ Pharyngitis, cellulitis (abscess formation
▪ Primarily infects skin, soft tissue in dermis, subcutaneous fat layers),
necrotizing fasciitis (progressive
Virulence factors destruction of deep soft tissue),
▪ Vary with specific strain impetigo
▪ M proteins ▪ Toxigenic disease
▫ Protect microbe from humoral ▫ Scarlet fever, toxic shock syndrome,
immune surveillance, phagocytosis by GAS endometritis (puerperal sepsis)
polymorphonuclear leukocytes ▪ Immunologic disease
▪ Binding proteins ▫ Rheumatic fever (antibodies against
▫ Bind to IgG, IgM, IgA → may interfere streptococcal cell cross-react with
with complement activation cardiac tissue); poststreptococcal
▫ Protein F: binds to fibronectin → ↑ glomerulonephritis (immune complexes
adherence to epithelial surfaces deposited in glomeruli)
▪ Cytolysins
▫ Streptolysins: bind to cholesterol on RISK FACTORS
eukaryotic cell membranes → cell lysis ▪ Susceptible host + encounter with
▫ Hyaluronidase: hydrolyzes hyaluronic streptococcus expressing specific virulence
acid → facilitates infection spread factors
▫ Streptokinase: proteolytically converts
bound plasminogen to active plasmin
→ cleavage of fibrin; medically useful as
COMPLICATIONS
clot-busting drug ▪ Local spread (e.g. otitis media, sinusitis,
mastoiditis); tissue destruction; valvular,
▫ Nicotinamide adenine dinucleotidase
renal disease; sepsis, shock, multiorgan
(NADase): exact function unclear; likely
failure; disseminated intravascular
↑ invasiveness
coagulation; pediatric autoimmune
▫ Deoxyribonuclease: promotes neuropsychiatric disorder associated with
production of anti-deoxyribonuclease group A streptococci (PANDAS)
(DNase) antibody following pharyngeal/
skin infections

[Link] 555
SIGNS & SYMPTOMS DIAGNOSIS
▪ Pharyngitis LAB RESULTS
▫ Acute onset of sore throat, fever,
Identification of microbe
pharyngeal edema, patchy tonsillar
exudates ▪ Gram positive cocci
▪ Cellulitis ▪ Positive culture
▫ Erythema, edema, abscess formation ▪ Blood studies
▪ Impetigo ▫ Rapid antigen detection test (RADT) for
GAS
▫ Papules, vesicles, pustules surrounded
by erythema pustules → breaks down,
forms crusts OTHER DIAGNOSTICS
▪ Scarlet fever ▪ Clinical history, physical examination
▫ Erythematous rash
▪ Toxic shock syndrome
▫ Shock, multiorgan failure
TREATMENT
▪ GAS endometritis MEDICATIONS
▫ Postpartum fever, uterine tenderness ▪ Antibiotics (e.g. penicillin G, clindamycin)

SURGERY
▪ Surgical debridement

STREPTOCOCCUS VIRIDANS
[Link]/streptococcus-viridans
infections (e.g. abdominal, central
PATHOLOGY & CAUSES nervous system, lung, skin, soft tissue,
sepsis)
▪ Heterogeneous collection of alpha/ ▫ Abscess formation
nonhemolytic streptococci, cause variety of
▫ Viridans streptococcal shock syndrome
diseases
▪ Some species produce greenish color on
blood agar plates RISK FACTORS
▪ Not bile soluble, optochin resistant ▪ Immunocompromised state
▪ Approx. 30 species classified into six ▪ Periodontal disease
groups ▪ More common in children than adults
▪ Part of microbiome of oropharynx, GI, ▪ Comorbidities (e.g. mucositis, cystic fibrosis,
genitourinary tract malignancies)
▪ May be invasive, produce variety of ▪ Altered microbiome
diseases
▫ Dental caries, periodontal disease,
maxillofacial infections, exudative SIGNS & SYMPTOMS
pharyngitis, infective endocarditis
▫ Invades circulation → systemic ▪ Clinical presentation varies widely
depending on infection

556 [Link]
Chapter 99 Streptococcus

DIAGNOSIS
LAB RESULTS
Identification of organism
▪ Gram-positive cocci, positive culture

OTHER DIAGNOSTICS
▪ Clinical history, physical examination

TREATMENT
MEDICATIONS
▪ Antibiotics (depending on sensitivity,
resistance)
▫ Penicillin + aminoglycoside; broad-
spectrum cephalosporin, vancomycin

SURGERY
▪ Abscess debridement/drainage

[Link] 557

Common questions

Powered by AI

Streptococcus agalactiae invades tissues using virulence factors like HvgA to cross the blood-brain barrier and CovR/S mutations to penetrate the amniotic membranes, primarily evading the immune system via capsular polysaccharides that inhibit complement deposition. In contrast, Streptococcus pyogenes uses M proteins to protect against phagocytosis and binding proteins to interfere with complement activation. Its pyrogenic exotoxins act as superantigens, causing immune hyperactivation that aids in immune evasion. While S. agalactiae focuses on crossing physical barriers, S. pyogenes employs aggressive immune modulation to facilitate tissue invasion .

Underlying chronic diseases like diabetes, liver disease, and malignancies compromise the immune system, making individuals more susceptible to infections by reducing the body's ability to fight off bacteria such as Streptococcus species. In adults over 65, an age-related decline in immune function, often exacerbated by comorbidities and increased exposure in settings like nursing homes, raises the risk of severe infections. These factors can lead to complications like pneumonia, meningitis, and sepsis. Therefore, chronic diseases and advanced age are key contributors to heightened vulnerability to severe streptococcal infections .

Clinical manifestations of Streptococcus pneumoniae, such as cough, fever, and difficulty breathing in pneumonia, guide the use of chest X-rays to confirm diagnoses by revealing infiltration and consolidation in the lungs. Symptoms indicative of meningitis, such as headache and neck stiffness, might prompt imaging of the brain via CT or MRI to assess complications. Tailoring imaging based on symptomatic presentations allows for accurate diagnosis and effective treatment planning .

Complications associated with Streptococcus pneumoniae infections include pneumococcal endocarditis, empyema, bacteremia, and sepsis. Clinically, endocarditis manifests with symptoms such as fever, heart murmur, and signs of heart failure, while empyema is characterized by chest pain, fever, and dyspnea due to pus in the pleural cavity. Bacteremia can result in systemic fever and malaise, potentially leading to septic shock with associated organ dysfunction and hemodynamic instability when severe .

Key virulence factors of Group B Streptococcus (GBS) include complex capsular polysaccharides, hypervirulent GBS adhesin (HvgA), CovR/S mutation, and pilins. The capsular polysaccharides inhibit complement deposition on the microbe surface, which prevents opsonization and subsequent phagocytosis. HvgA increases the bacterium's ability to invade the blood-brain barrier, while CovR/S mutation accelerates failure of the amniotic barrier, enhancing penetration through chorioamniotic membranes. Pilins act as adhesins which aid in central nervous system invasion and biofilm formation .

The CAMP test is used in diagnostics to identify Streptococcus agalactiae by exploiting the production of CAMP factor, which synergistically interacts with beta-hemolysin produced by Staphylococcus aureus to cause an enhanced zone of hemolysis on blood agar. This characteristic arrowhead pattern differentiates it from other streptococci, confirming the presence of GBS. This test is particularly useful for distinguishing GBS from non-group B streptococci, ensuring accurate identification and effective treatment .

Risk factors for Streptococcus pneumoniae infections in children (<2 years) primarily include age due to immature immune responses. In adults (≥65 years), risk factors involve underlying diseases such as liver, kidney, heart conditions, lung disorders, diabetes, and malignancies. Crowded conditions like daycares, military camps, and prisons can increase risk due to greater exposure. Immunodeficiency, either congenital or acquired (e.g., HIV, solid organ/bone transplants), also increases susceptibility in both population groups. Additionally, behaviors such as smoking and alcohol abuse are significant risk factors in adults .

Streptococcus pyogenes possesses a variety of virulence factors which enhance its pathogenicity. M proteins help it evade immune responses by protecting against phagocytosis. Cytolysins such as streptolysins cause lysis of host cells. Hyaluronidase and streptokinase promote tissue invasion and spread by breaking down connective tissue barriers and fibrin clots. Pyrogenic exotoxins act as superantigens, inducing high levels of cytokine production and fever, which can lead to toxic shock syndrome. These factors collectively enable S. pyogenes to cause a range of diseases, from mild pharyngitis to severe systemic conditions like toxic shock syndrome .

Antibiotic resistance in Streptococcus pneumoniae, particularly against beta-lactam antibiotics, is primarily due to alterations in penicillin-binding proteins, which reduce binding efficacy to penicillin and related antibiotics, rendering them less effective. This necessitates the use of alternative antibiotics like macrolides or quinolones, or combination therapies that can circumvent the resistance mechanisms. Monitoring antibiotic susceptibility is crucial in tailoring treatment strategies, and the implementation of pneumococcal vaccines helps decrease antibiotic resistance by preventing infections and subsequently reducing antibiotic use .

Common diagnostic tests for Streptococcus pyogenes include Gram stain, culture, and Rapid Antigen Detection Test (RADT). Gram stain confirms the presence of Gram-positive cocci, while cultures allow for growth identification on blood agar, demonstrating beta-hemolysis, a complete clearness around colonies. RADT quickly detects presence of Group A Streptococcus antigens directly from throat swabs, facilitating rapid identification compared to slower culture techniques .

You might also like